BamSEC and AlphaSense Join Forces
Learn More

Bambusa Therapeutics Inc. – Material Contracts

NASDAQ: BBTX    
Share price (11/4/26): $16.07    
Market cap (11/4/26): $649 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.11
from S-1/A 41 pages Amended and Restated Assignment Agreement
12/34/56
EX-10.10
from S-1/A 10 pages Bambusa Therapeutics, Inc. Confirmatory Executive Offer Letter October 16, 2026
12/34/56
EX-10.9
from S-1/A 10 pages Bambusa Therapeutics, Inc. Confirmatory Executive Offer Letter October 16, 2026
12/34/56
EX-10.8
from S-1/A 10 pages Bambusa Therapeutics, Inc. Confirmatory Executive Offer Letter October 16, 2026
12/34/56
EX-10.5
from S-1/A 5 pages Bambusa Therapeutics, Inc. Outside Director Compensation Policy
12/34/56
EX-10.4
from S-1/A 84 pages Bambusa Therapeutics, Inc. 2024 Stock Plan Amended and Restated: October 22, 2026
12/34/56
EX-10.3
from S-1/A 27 pages Bambusa Therapeutics, Inc. 2026 Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-1/A 54 pages Bambusa Therapeutics, Inc. 2026 Equity Incentive Plan
12/34/56
EX-10.13
from S-1 98 pages Exclusive License Agreement by and Between Bambusa Therapeutics, Inc. and Biotheus Inc
12/34/56
EX-10.12
from S-1 32 pages Research Collaboration and Option Agreement
12/34/56
EX-10.11
from S-1 98 pages Exclusive License Agreement by and Between Bambusa Therapeutics, Inc. and Biotheus Inc
12/34/56
EX-10.7
from S-1 18 pages Bambusa Therapeutics, Inc. Change in Control and Severance Plan and Summary Plan Description
12/34/56
EX-10.6
from S-1 9 pages Bambusa Therapeutics, Inc. Employee Incentive Compensation Plan
12/34/56
EX-10.4
from S-1 84 pages Bambusa Therapeutics, Inc. 2024 Stock Plan Amended and Restated: October 5, 2026
12/34/56
EX-10.1
from S-1 14 pages Bambusa Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.8
from DRS/A 98 pages Exclusive License Agreement by and Between Bambusa Therapeutics, Inc. and Biotheus Inc
12/34/56
EX-10.7
from DRS/A 32 pages Research Collaboration and Option Agreement
12/34/56
EX-10.6
from DRS/A 41 pages Amended and Restated Assignment Agreement
12/34/56
EX-10.4
from DRS/A 83 pages Bambusa Therapeutics, Inc. 2024 Stock Plan
12/34/56